Background: The use of over-the-counter products, herbals, and vitamins or supplements (collectively termed "nonprescription medications") is common among individuals with cardiovascular disease. We sought to determine patterns and predictors of nonprescription medication use and assessed whether different survey methodology may result in variable patient reporting of these products.

Methods And Results: We surveyed 161 patients with heart failure. The first 80 participants were provided a written survey to complete during their clinic appointment, and the next 80 age-matched participants met with study personnel for survey administration via face-to-face interview. Over-the-counter product use was reported by 88% of participants, whereas 34.8% took herbal supplements, and 65.2% took vitamins or supplements. Users of nonprescription medications were older, more likely to have an ischemic etiology, and concomitant chronic conditions. No differences in reporting were noted for patient versus provider-administered surveys. Discrepancies between survey and medical record data were common (40.4%), occurring most frequently with nonprescription aspirin, proton pump inhibitors, magnesium, and acetaminophen.

Conclusions: The majority of study participants used nonprescription medications, and often did not report usage to health care providers. Patient education regarding importance of disclosure of nonprescription medications is crucial, as is consistent querying of use by heart failure providers.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cardfail.2013.10.009DOI Listing

Publication Analysis

Top Keywords

heart failure
12
nonprescription medications
12
nonprescription medication
8
patients heart
8
vitamins supplements
8
nonprescription
6
medication patients
4
failure assessment
4
assessment methods
4
methods utilization
4

Similar Publications

Pharmacologic Management of Heart Failure with Preserved Ejection Fraction (HFpEF) in Older Adults.

Drugs Aging

January 2025

Program for the Care and Study of the Aging Heart, Department of Medicine, Weill Cornell Medicine, 420 East 70th St, New York, NY, LH-36510063, USA.

There are several pharmacologic agents that have been touted as guideline-directed medical therapy for heart failure with preserved ejection fraction (HFpEF). However, it is important to recognize that older adults with HFpEF also contend with an increased risk for adverse effects from medications due to age-related changes in pharmacokinetics and pharmacodynamics of medications, as well as the concurrence of geriatric conditions such as polypharmacy and frailty. With this review, we discuss the underlying evidence for the benefits of various treatments in HFpEF and incorporate key considerations for older adults, a subpopulation that may be at higher risk for adverse drug events.

View Article and Find Full Text PDF

Novel Therapies for Right Ventricular Failure.

Curr Cardiol Rep

January 2025

Pediatric Advanced Heart Failure and Heart Transplant Program, University of Mississippi Medical Center, 2500 N State Street, Jackson, MS, USA.

Purpose Of Review: Traditionally viewed as a passive player in circulation, the right ventricle (RV) has become a pivotal force in hemodynamics. RV failure (RVF) is a recognized complication of primary cardiac and pulmonary vascular disorders and is associated with a poor prognosis. Unlike treatments for left ventricular failure (LVF), strategies such as adrenoceptor signaling inhibition and renin-angiotensin system modulation have shown limited success in RVF.

View Article and Find Full Text PDF

Recent evidence suggests that ketone bodies have therapeutic potential in many cardiovascular diseases including heart failure (HF). Accordingly, this has led to multiple clinical trials that use ketone esters to treat HF patients, which we term ketone therapy. Ketone esters, specifically ketone monoesters, are synthetic compounds which, when consumed, are de-esterified into two β-hydroxybutyrate (βOHB) molecules and increase the circulating βOHB concentration.

View Article and Find Full Text PDF

The acute response to therapeutic afterload reduction differs between heart failure with preserved (HFpEF) versus reduced ejection fraction (HFrEF), with larger left ventricular (LV) stroke work augmentation in HFrEF compared to HFpEF. This may (partially) explain the neutral effect of HFrEF-medication in HFpEF. It is unclear whether such differences in hemodynamic response persist and/or differentially trigger reverse remodeling in case of long-term afterload reduction.

View Article and Find Full Text PDF

Obesity, along with hypoxia, is known to be a risk factor for pulmonary hypertension (PH), which can lead to right ventricular hypertrophy and eventually heart failure. Both obesity and PH influence the autonomic nervous system (ANS), potentially aggravating changes in the right ventricle (RV). This study investigates the combined effects of obesity and hypoxia on the autonomic innervation of the RV in a mouse model.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!